Skip to main content
. Author manuscript; available in PMC: 2019 Jan 1.
Published in final edited form as: Psychooncology. 2017 Jul 13;27(1):325–332. doi: 10.1002/pon.4469

TABLE 1.

Participant characteristics by treatment preferencea

Variable All (N = 761) N (Column %) Treatment Preference
AS/WW (N = 417) N (Row %) RP (N = 198) N (Row %) EBRT (N = 69) N (Row %) BRAC (N = 77) N (Row %) P Value
Age in years (median, IQR) (62, 11) (63, 9) (58, 11) (66, 7) (61, 11) <.001
Age by category <.001
 <50 51 (6.7) 17 (33.3) 24 (47.1) 2 (3.9) 8 (15.7)
 50–59 249 (32.7) 121 (48.6) 91 (36.5) 10 (4.0) 27 (10.8)
 60–69 373 (49) 219 (58.75) 78 (20.9) 43 (11.5) 33 (8.8)
 70+ 88 (11.6) 60 (68.2) 5 (5.7) 14 (15.9) 9 (10.2)
Days from diagnosis (median, IQR) (25, 14) (26, 16) (25, 14) (25, 9) (23, 17) .13
Race .02
 White 623 (81.9) 347 (55.7) 150 (24.1) 63 (10.1) 63 (10.1)
 Black 85 (11.2) 37 (43.5) 32 (37.6) 5 (5.9) 11 (12.9)
 Other 53 (7) 33 (62.3) 16 (30.2) 1 (1.9) 3 (5.7)
Ethnicity .03
 Hispanic 93 (12.4) 46 (49.5) 35 (37.6) 4 (4.3) 8 (8.6)
 Non-Hispanic 657 (87.6) 360 (54.8) 162 (24.7) 66 (10.0) 162 (24.7)
Marital status <.01
 Married/relationship 619 (81.4) 330 (53.3) 177 (28.6) 58 (9.4) 54 (8.7)
 Separated/divorced/widowed 115 (15.1) 71 (61.7) 19 (16.5) 7 (6.1) 18 (15.7)
 Never married 26 (3.4) 15 (57.7) 2 (7.7) 4 (15.4) 5 (19.2)
Education .02
 ≤High school 164 (21.6) 83 (50.6) 50 (30.5) 13 (7.9) 18 (11.0)
 Some college 251 (33.1) 137 (54.6) 64 (25.5) 26 (10.4) 24 (9.6)
 College graduate 165 (21.8) 82 (49.7) 41 (24.8) 14 (8.5) 28 (17.0)
 Graduate school/degree 178 (23.5) 112 (62.9) 43 (24.2) 16 (9.0) 7 (3.9)
Employment <.001
 Employed 432 (57.4) 235 (54.4) 131 (30.3) 25 (5.8) 41 (9.5)
 Retired 283 (37.6) 157 (55.5) 55 (19.4) 41 (14.5) 30 (10.6)
 Not employed/disabled 37 (4.9) 16 (43.2) 12 (32.4) 3 (8.1) 6 (16.2)
Income .55
 ≤$75,000 269 (37.9) 144 (53.5) 65 (24.2) 26 (9.7) 34 (12.6)
 $75,000–125,000 234 (100) 134 (57.3) 22 (9.4) 21 (9.0) 57 (24.4)
 >$125,000 206 (29.1) 105 (51.0) 66 (32.0) 18 (8.7) 17 (8.3)
Comorbidity (Elixhauser) .59
 0 263 (34.6) 143 (54.4) 72 (27.4) 22 (8.4) 26 (9.9)
 1 205 (26.9) 116 (56.6) 56 (27.3) 12 (5.9) 21 (10.2)
 2 114 (15) 57 (50.0) 29 (25.4) 15 (13.2) 13 (11.4)
 3+ 179 (23.5) 101 (56.4) 41 (22.9) 20 (11.2) 17 (9.5)
PSA level .03
 ≤4 ng/mL 82 (10.8) 37 (45.1) 31 (37.8) 4 (4.9) 10 (12.2)
 >4–10 ng/mL 679 (89.2) 380 (56.0) 167 (24.6) 65 (9.6) 67 (9.9)
a

Number of respondents within each category may not be the same as total due to missing data.

Abbreviations: AS/WW indicates active surveillance/watchful waiting; RP, radical prostatectomy; EBRT, external beam radiotherapy; BRAC, brachytherapy; PSA, prostate-specific antigen.